PMAM
BNTX icon

Picton Mahoney Asset Management’s BioNTech BNTX Stock Holding History

Picton Mahoney Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,100
Closed -$187K – 865
2022
Q1 		$187K Buy
+1,100
New +$185K 0.01% 663
2021
Q4 		– Sell
-600
Closed -$164K – 967
2021
Q3 		$164K Buy
+600
New +$191K 0.01% 609

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Picton Mahoney Asset Management's BNTX Position: Q2 2022 in Review

Picton Mahoney Asset Management sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 1,100 shares — an estimated $187K sold.

Picton Mahoney Asset Management first reported a position in BNTX in Q3 2021 and held it in 2 quarters. The position peaked at $187K in Q1 2022. 293 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

  • Picton Mahoney Asset Management reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 1,100 BioNTech shares in Q2 2022, an estimated $187K.
  • Picton Mahoney Asset Management first reported a position in BioNTech in Q3 2021 and held it in 2 quarters.
  • Picton Mahoney Asset Management's BioNTech position peaked at $187K in Q1 2022.
  • 293 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.